Entity Common Stock, Shares Outstanding of REGENEREX PHARMA, INC. from Q3 2011 to Q4 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
REGENEREX PHARMA, INC. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2011 to Q4 2025.
  • REGENEREX PHARMA, INC. Entity Common Stock, Shares Outstanding for the quarter ending 17 Nov 2025 was 282,372,310, a 1.4% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

REGENEREX PHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 282,372,310 +3,906,400 +1.4% 17 Nov 2025 10-Q 17 Nov 2025 2025 Q2
Q2 2025 281,070,910 +2,845,000 +1% 30 Jun 2025 10-K 30 Jun 2025 2024 FY
Q4 2024 278,465,910 +470,000 +0.17% 07 Feb 2025 10-Q 07 Feb 2025 2024 Q3
Q3 2024 278,435,910 +520,000 +0.19% 04 Nov 2024 10-Q 04 Nov 2024 2024 Q2
Q2 2024 278,225,910 +1,078,250 +0.39% 24 Jun 2024 10-K 24 Jun 2024 2023 FY
Q4 2023 277,995,910 +883,250 +0.32% 05 Feb 2024 10-Q 05 Feb 2024 2023 Q3
Q3 2023 277,915,910 +803,250 +0.29% 08 Nov 2023 10-Q 08 Nov 2023 2023 Q2
Q2 2023 277,147,660 +35,000 +0.01% 09 Jun 2023 10-K 09 Jun 2023 2023 FY
Q4 2022 277,112,660 0 0% 24 Jan 2023 10-Q 24 Jan 2023 2022 Q3
Q3 2022 277,112,660 +150,000,000 +118% 07 Nov 2022 10-Q 07 Nov 2022 2022 Q2
Q2 2022 277,112,660 +150,000,000 +118% 28 Jun 2022 10-K 28 Jun 2022 2022 FY
Q4 2021 277,112,660 +150,000,000 +118% 02 Feb 2022 10-Q/A 03 Feb 2022 2021 Q3
Q3 2021 127,112,660 0 0% 01 Nov 2021 10-Q 01 Nov 2021 2021 Q2
Q2 2021 127,112,660 0 0% 23 Jun 2021 10-K 23 Jun 2021 2020 FY
Q4 2020 127,112,660 0 0% 12 Feb 2021 10-Q 11 Feb 2021 2020 Q3
Q3 2020 127,112,660 10 Nov 2020 10-Q 10 Nov 2020 2020 Q2
Q2 2020 127,112,660 0 0% 23 Jun 2020 10-K/A 11 Aug 2020 2019 FY
Q4 2019 127,112,660 0 0% 11 Feb 2020 10-Q 10 Feb 2020 2019 Q3
Q2 2019 127,112,660 0 0% 15 Jul 2019 10-Q 30 Oct 2019 2019 Q2
Q1 2019 127,112,660 15 May 2019 10-K 24 Jun 2019 2018 FY
Q4 2018 127,112,660 +10,250,000 +8.8% 30 Jan 2019 10-Q 04 Feb 2019 2018 Q3
Q3 2018 127,112,660 -28,950,000 -19% 12 Nov 2018 10-Q 13 Nov 2018 2018 Q2
Q2 2018 127,112,660 -28,950,000 -19% 21 Jun 2018 10-K 21 Jun 2018 2017 FY
Q4 2017 116,862,660 08 Feb 2018 10-Q 08 Feb 2018 2017 Q3
Q3 2017 156,062,660 18 Oct 2017 10-Q 07 Nov 2017 2017 Q2
Q2 2017 156,062,660 28 Jul 2017 10-Q 07 Aug 2017 2017 Q1
Q4 2014 156,412,660 +5,279,660 +3.5% 30 Jan 2015 10-K 03 Mar 2015 2014 FY
Q3 2014 156,412,660 +5,289,660 +3.5% 10 Oct 2014 10-Q 20 Oct 2014 2014 Q3
Q2 2014 151,158,000 +151,158,000 03 Jul 2014 10-Q 23 Jul 2014 2014 Q2
Q1 2014 151,158,000 +2,080,000 +1.4% 08 Apr 2014 10-Q 11 Apr 2014 2014 Q1
Q4 2013 151,133,000 +2,055,000 +1.4% 06 Jan 2014 10-K 28 Feb 2014 2013 FY
Q3 2013 151,123,000 +5,065,000 +3.5% 30 Sep 2013 10-Q 02 Oct 2013 2013 Q3
Q2 2013 0 -141,048,000 -100% 31 May 2013 10-Q 15 Jul 2013 2013 Q2
Q1 2013 149,078,000 +8,035,000 +5.7% 28 Feb 2013 10-Q 12 Apr 2013 2013 Q1
Q4 2012 149,078,000 10 Jan 2013 10-K/A 28 Feb 2013 2012 FY
Q3 2012 146,058,000 -24,942,000 -15% 12 Oct 2012 10-Q 15 Oct 2012 2012 Q3
Q2 2012 141,048,000 12 Jul 2012 10-Q 16 Jul 2012 2012 Q2
Q1 2012 141,043,000 11 Apr 2012 10-Q 16 Apr 2012 2012 Q1
Q3 2011 171,000,000 30 Sep 2011 10-Q 13 Oct 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.